| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |